Skip to main content

Table 2 Examination data on presentation and follow-up

From: A patient with glycogen storage disease type Ia combined with chronic hepatitis B infection: a case report

Variable

Reference range

Baseline

9 Months

12 Months

18 Months

Blood glucose (mmol/L)

3.9–6.4

3.19

3.58

4.15

3.43

Triglyceride (mmol/L)

0.4–1.73

5.76

4.17

3.32

2.98

Total cholesterol (mmol/L)

3.1–5.7

5.51

5.54

6.57

5.95

LDL-cholesterol (mmol/L)

2.07–3.1

4.06

3.94

4.49

4.06

HDL- cholesterol (mmol/L)

0.9–2.0

1.45

1.6

2.07

1.89

Testosterone (ng/ml)

1.75–7.81

0.78

2.55

2.78

1.8

Uric acid (μmol/L)

155–428

493.2

639.2

509.5

580.2

Creatine (μmol/l)

25–104

33.2

36.5

41.6

33.9

Urea (mmol/L)

1.7–8.3

2.5

1.7

4.6

3.4

Growth hormone (ng/ml)

0.55–4.47

0.62

3.73

25.24

Urine Ketone

negative

Weakly positive

Weakly positive

Height (cm)

138

152

155

Weight (kg)

29

35.8

36

BMI

15.23

15.50

14.98

Hepatic adenoma(n, min, max(mm))

7, 7, 23

7, 10, 27

7, 11, 34

7, 12, 34

Corn starch therapy

Started taking

not follow the scheduled treatment for last 3 months

Continuously taking

Continuously taking

Radiofrequency ablation

Done